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Background/aim: This study’s aim was to investigate the effects of thymoquinone, which is the essential bioactive component of the
volatile oil of Nigella sativa on the peridural fibrosis in rats following laminectomy.
Materials and methods: Twenty female Wistar Albino rats were used in our study. The rats were randomly divided into 2 groups:
Sham and Surgery + Thymoquinone. Both groups underwent laminectomy at L1 under general anesthesia. The Sham group was not
subjected to any drug application. The 2nd group was treated with intraperitoneal 10-mg/kg thymoquinone once per day for a period of
28 days, following the same surgical procedure. All of the group specimens were sacrificed after 4 weeks, and the laminectomy area was
examined in terms of new bone volume, capillary volume, and fibrosis volume using stereological approaches.
Results: Statistically significant differences were found between the Sham and Surgery + Thymoquinone groups in terms of new bone
volume (P = 0.01), capillary volume (P = 0.01), and fibrosis volume (P < 0.001). It was noted that Thymoquinone caused a significant
increase in new bone volume, vascular volume and, a significant decrease in fibrosis volume.
Conclusion: The results of our study indicate that thymoquinone is effective in decreasing peridural fibrosis when applied to a
laminectomy model.
Key words: Laminectomy, peridural fibrosis, thymoquinone

1. Introduction
Annually, a large number of people undergo surgery of
the lumbosacral region, making this operation one of the
most applied treatments for spinal disorders [1,2]. The
failed back syndrome is identified as a persistent pain in
the lower back, leg, hip, and thigh in patients who have
had the surgical procedure known as a laminectomy. It
is also called a postlaminectomy syndrome (PLS) [3].
Inappropriate application of the surgical procedure,
the disruption of the internal disc, spinal stenosis, and
peridural fibrosis are among the possible causes of failed
back syndrome [4,6]. Peridural fibrosis is known as one
of the most common causes of failed back syndrome and
possesses characteristic features such as the accumulation
of scar tissue between the dura mater and surrounding
tissues [7]. The formation of the scar tissue causes the
nerve roots to become more prone to damage by disc
protrusions by restricting their movement. Peridural
fibrosis is suggested as one of the primary causes of pain
following spinal surgeries [8]. In the literature, there are

no established treatments of peridural fibrosis, and some
painkiller drugs are utilized for the alleviation of pain
[9]. As the granulation tissue is formed following surgery,
peridural fibrosis may increase the incidence of surgical
complications [10].
Thymoquinone is the bioactive compound of the
volatile oil of black cumin (C10H10O2; 2-isopropyl-5methyl-1, 4-benzoquinone). Thymoquinone is acquired
from the seeds of Nigella sativa that are bound up in the
Ranunculaceae family [11,12]. Thymoquinone has been
used for various purposes such as for its antioxidant,
antiinflammatory,
immunomodulator,
anticancer,
antimicrobial, antihistaminic, and antineoplastic
properties [13–15]. Thymoquinone inhibits the
cyclooxygenase (COX) and lipoxygenase (LO) pathways,
which are the enzymes that mediate inflammation [16].
Moreover, it was determined that Thymoquinone inhibits
the capacity to produce cellular LO, which is synthesized
for L-arginine in the presence of the enzyme nitric
oxide synthase and is associated with several disorders.
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Thymoquinone is known to inhibit NO production at a
percentage of 95% [17,18].
Several studies about peridural fibrosis can be found in
the literature. Some previous research has indicated that
antineoplastic agents like mitomycin C, 5-Fluorouracil,
and cyclosporin reduce peridural fibrosis, although there
are side effects and the cost is high. Furthermore, there
are studies focusing on the external particle radiation but
no beneficial effects on peridural fibrosis have yet been
determined. The solution for the problem of peridural
fibrosis is continuously being researched [19–21], but a
standard approach and treatment protocol have not been
previously established.
In this study, we aimed to investigate the possible effects
of intraperitoneal application of Thymoquinone, which is
the basic bioactive compound of the Nigella sativa volatile
oil, on the experimental laminectomy model of rats with
histopathological and stereological methods.
2. Materials and methods
2.1. Experimental animals
This study was performed following the ethical approval of
Ondokuz Mayıs University (2014/30), in Ondokuz Mayıs
University’s Experimental Animals Research Center. In
this experimental study, 20 female Wistar Albino rats,
weighting between 280–300 g were used. All of the subjects
were kept in rooms with stable temperature and humidity,
given normal tap water, and fed rat pellets without any
limitation or additional food. The histopathological and
stereological evaluations of the samples were performed in
the Department of Histology and Embryology laboratories
at the Faculty of Medicine of Ondokuz Mayıs University.
Two groups were determined in the experimental
design: the first was the Sham group. In this group, 10
rats were subjected to the operational laminectomy
procedure at the L1 level. The 2nd group, the Surgery
+ Thymoquinone group, consisted of 10 rats that were
subjected to same laminectomy operation. After the
operation, Thymoquinone was applied intraperitoneally
for 28 days at a dose of 10 mg/kg/day [22].
2.2. Procedure
For prophylactic purposes, a single dose of 50-mg/kg
ceftriaxone (Rocephine, Roche, Turkey) was applied
intraperitoneally 30 min before the operation. General
anesthesia was established in the rats, which were not
given any food 1 night prior to the operation, with an
intraperitoneal injection of a mixture of Ketamine (50 mg/
kg) (Ketalar, Eczacıbaşı, Turkey) and Xylazine (10 mg/kg)
(Rompun 2%, Bayer, Turkey). The anesthesia was regulated
to keep the rats unresponsive to painful stimuli without
interrupting their spontaneous respiration; additional
doses were given when required.
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2.2.1. Formation of the laminectomy model
The rats were kept stable by having their extremities and
their tails set in a prone position on specially manufactured
wooden platforms. The surgical areas were then shaved,
and disinfection was performed with povidone iodine
solution (POVIOD; 10% polyvinylpyrrolidone-iodine
complex, Saba, Turkey). The operational area was covered
with sterile coverings. A 3-cm skin incision was made on
the spinous processes with lumbar 1 vertebra in the middle
of the incision, and the paraspinous muscles were then
removed with blunt dissection. Small automatic retractors
were used to uncover laminas and spinous processes.
With the help of a surgical microscope (Leica RM 2135,
Leica Instruments, Nussloch, Germany), dura mater was
exposed by making a total laminectomy to the L1 vertebra
(Figures 1A and 1B). The layers were properly closed in all
groups following hemostasis [23].
2.2.2. Intraperitoneal application of thymoquinone:
The surgery day was noted as day 0 and immediately after,
intraperitoneal Thymoquinone was applied to Surgery +
Thymoquinone group subjects at a dose of 10 mg/kg/day
for 28 days.
The Sham and Surgery + Thymoquinone groups were
both handled in their own cages. At the end of the 4 weeks,
they were sacrificed with intraperitoneal high-dose (75-100
mg/kg) Thiopental sodium (Pentothal Sodium, Abbott,
Italy). During the collection of the samples, the animals
were checked for dura tear, nerve damage, and infection.
There were no spotted dura tear or infections in the rats.
The vertebral columns were removed and were put in 10%
formaldehyde for histological tissue processing.
2.3. Histological analysis
The vertebrae samples obtained from the subjects were
kept in 10% formaldehyde solution for postfixation for 1
week and then decalcified in 5% formic acid solution for
21 days. The light microscopical routine histological tissue
processing steps were performed for the samples following
decalcification. Ten micrometer sections in thickness
were taken from every paraffin block in accordance with
stereological approaches from the results of the pilot study
and stained with Hematoxylin and Eosin.
The section-sampling fraction was determined as
1/4, and the sections were taken in 10-µm thickness. The
point density of the grid was determined according to the
coefficient of error [24]. The volume estimations of new
bone, new capillary, and fibrosis in the laminectomy area
were performed according to the Cavalieri method (Figure
2A–2D), using the following formula [25].
Area = a/p (µm x µm) × (ΣP) µm2
a/p: area between 2 points
ΣP: the total number of points intersecting with the
area of interest
Volume = t × a/p × ΣP
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Figure 1. Photo of the paravertebral muscle and fascia (A) and exposure of the spinous process after the incision (B).

2.4. Statistical analysis
The SPSS 20 (IBM Corp., Armonk, NY, USA) program
was used for the statistical evaluation of the data. Student’s
t-test was used for comparing the groups. P values less
than 0.05 were accepted as statistically significant.
3. Results
The new bone volumes of the Sham and Surgery +
Thymoquinone groups were found to be 1.495 ± 0.075
(mean ± SEM) µm3 and 2.265 ± 0.133 µm3, respectively.
There was significant difference between the groups (P =
0.01) (Figure 3A, 3B).
Regarding new capillary volume, it was found to be
0.780 ± 0.131 µm3 in the Sham group and 1.897 ± 0.09 µm3
in the Surgery + Thymoquinone group, respectively. There
was statistically significant difference between the groups
(P = 0.01) (Figure 3A, 3B).
The mean fibrosis volume was found to be 3.151 ±
0.147 µm3 in the Sham group and 1.936 ± 0.095 µm3 in
the Surgery + Thymoquinone group, respectively. Similar
to the previous parameters, there was also significant
statistical difference between the groups (P < 0.001)
(Figure 3A, 3B).
3. Discussion
Lumbar pain is one of the most common medical
complaints and the second most common reason for
seeking professional medical help [26]. It is estimated that
approximately 200,000–350,000 patients in the US undergo
lumbar surgery due to reasons such as discogenic back
pain, trauma, tumor, spondylolisthesis, and spinal stenosis

[20]. In the laminectomy area, the fibroblast population
increases due to activation of the inflammatory cytokines.
Growth factors for the repair of local defective vertebral
area and large amounts of collagen fibers are formed.
With the occurrence of collagen fibers, fibroblasts become
fibrocytes. Scar tissue is formed from fibrous connective
tissue [27]. Compression of the spinal cord due to peridural
fibrosis may lead to the occurrence of unwanted clinical
results following surgery [4,28]. The scar tissue that might
follow the surgical operation can cause constriction of the
nerve root and stenosis [29]. Although it is not completely
clear how clinical symptoms and adhesion formations are
related, peridural fibrosis is associated with many cases of
failed back surgery [28]. Besides the radicular symptoms
due to nerve constriction, scar formation may also cause
increased durotomy during revision surgeries [30]. The
process of fibrosis is regulated by myofibroblast cells as
they produce collagen fibers [31]. The exact mechanism
behind the formation of peridural fibrosis after surgery
has not yet been clearly explored. A previous study
reported that the laminectomy membrane is formed due
to the invasion of fibroblasts from spinal muscles [32].
Peridural adhesion following spinal surgery might lead
to the secretion of vasoactive factors and inflammation,
which consequently result in collagen formation and the
infiltration of fibroblasts and macrophages.
Thymoquinone, which is the basic component of the
volatile oil of Nigella sativa, has the formula (C10H10O2;
2-isopropyl-5-methyl-1,4-benzoquinone) and has been
used for years as an antioxidant, antiinflammatory,
and antineoplastic agent [13,14]. In their study, Awad
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Figure 2. Application of Cavalier’s principle on the sections. Point-counted grid (A) was used to perform
the stereology. Every point represents a certain area (A and B) and, after putting the point-counted grid on
the section, counting was performed to obtain the total area of the related parameters (C and D).

et al. stated that thymoquinone is promising agent for
defense against fibrosis, hepatic steatosis, oxidative
stress, and inflammatory apoptosis [33]. Moreover, it
was also previously suggested that thymoquinone is a
scavenger of free radicals and superoxide radicals and
that it protects the functionality of various antioxidant
enzymes [34]. In their study, Pourgholamhossein et al.
demonstrated that thymoquinone is protective against
lung fibrosis as it displays features of oxidative stress
inhibition and profibrotic gene down regulation [35].
In addition, thymoquinone is currently being used for
cancer treatment [36]. Ahmad et al. found that it has the
potential to be a chemopreventive agent in cancer studies
and use in antitumor therapeutic paradigms [37].
Thymoquinone is used in the management of
inflammatory and autoimmune diseases as it inhibits
NO production approximately at 95% [17]. Also,
thymoquinone has an inhibition effect on COX and
LO pathways in the arachidonic acid metabolisms of
rat peritoneal leucocytes [38]. Besides, in an allergic
airway inflammation model in rats, thymoquinone
caused inhibition of PGD2 and COX-2, resulting in an
antiinflammatory effect [39].
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In the current study, the aim was to assess the effect of
thymoquinone application following laminectomy on new
bone formation. When the results were evaluated, it was
observed that thymoquinone application causes significant
increase in new bone volume and vascular volume (P = 0.01),
whereas it caused a significant decrease in fibrosis volume (P
< 0.001). These results are in agreement with the results of the
previous study of Wirries et al., in which they suggested that
Thymoquinone may induce osteogenesis [40]. In a previous
study, Kirui et al. showed that sustained thymoquinone
application increases bone healing [41]. Also, there are
several studies that demonstrated that thymoquinone
application has protective and beneficial features against
spinal cord ischemia/reperfusion injury as it decreased the
concentration of oxidative products, as well as the reduction
of neuropathic pain in parallel to our results [42,43].
Masson’s Trichrome staining is one of the best ways to
show peridural fibrosis. However, in this study, we showed
quantitative evaluation of peridural fibrosis stereologically;
therefore, we prefered H & E staining as this staining method
is feasible for stereological estimation.
Although further physiological, biochemical, and
electron microscopical examinations, such as investigating
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Figure 3. Representative histological images show the laminectomy areas in the Sham (A) and Surgery + Thymoquinone (B)
groups, respectively (Arrowheads: Capillaries exist in the fibrosis area (F); Black arrow: New bone; L: Lamina).

hydroxyproline levels are required, our study may guide
future studies and contribute to the scientific literature. It
is also important to compare the effect of Thymoquinone
with a standard drug or investigate the local use of
thymoquinone as a different group in future studies. We
are of the opinion that the presented results can enlighten
the way for more researchers studying this area.

Conflict of Interest
The authors declare no conflict of interest.
Informed Consent
Ethical approval was obtained from the Ondokuz Mayıs
University’s Animal Studies Local Ethics Committee with
number 2014-30.

References
1.

Burton CV. Lumbosacral arachnoiditis. Spine (Phila Pa 1976)
1978; 3 (1): 24-30. doi: 10.1097/00007632-197803000-00006

2.

Fiume D, Sherkat S, Callovini GM, Parziale G, Gazzeri G.
Treatment of the failed back surgery syndrome due to lumbosacral epidural fibrosis. Acta Neurochirurgica. Supplement
1995; 64: 116-118. doi: 10.1007/978-3-7091-9419-5_25

3.

Kazanci A, Gurcan O, Gurcay AG, Onder E, Kazanci B et
al. Effects of topical Cova™, Tisseel(R) and Adcon(R) gel
application on the development of spinal peridural fibrosis: an
experimental study in rats. Turkish Neurosurgery 2017; 27 (6):
962-968. doi: 10.5137/1019-5149.JTN.16809-15.1

7.

Skaf G, Bouclaous C, Alaraj A, Chamoun R. Clinical outcome
of surgical treatment of failed back surgery syndrome. Surgical
Neurology 2005; 64 (6): 483-488, discussion 488-489. doi:
10.1016/j.surneu.2005.04.009

8.

Hernández Vaquero D, Rubio González A, Romo Contreras I,
Amigo Fernández A, Domínguez Gil I. La fibrosis peridural como
complicación de la discectomía quirúrgica. Revista Brasileira de
Ortopedia 1990; 34: 372-376 (in Brazilian Portuguese).

9.

De Tribolet N, Porchet F, Lutz TW, Gratzl O, Brotchi J et
al. Clinical assessment of a novel antiadhesion barrier gel:
prospective, randomized, multicenter, clinical trial of ADCON-L
to inhibit postoperative peridural fibrosis and related symptoms
after lumbar discectomy. The American Journal of Orthopedics
1998; 27 (2): 111-120.

4.

North RB, Campbell JN, James CS, Conover-Walker MK,
Wang H et al. Failed back surgery syndrome: 5-year follow-up
in 102 patients undergoing repeated operation. Neurosurgery
1991; 28 (5): 685-690; discussion 690-691.

10.

5.

Siqueira EB, Kranzler LI, Dharkar DD. Fibrosis of the dura
mater: a cause of “failed back” syndrome. Surgical Neurology
1983; 19 (2): 168-170. doi: 10.1016/0090-3019(83)90418-4

Cauchoix J, Ficat C, Girard B. Repeat surgery after disc
excision. Spine (Phila Pa 1976) 1978; 3 (3): 256-259. doi:
10.1097/00007632-197809000-00011

11.

6.

Slipman CW, Shin CH, Patel RK, Isaac Z, Huston CW et al.
Etiologies of failed back surgery syndrome. Pain Medicine: The
Official Journal of the American Academy of Pain Medicine
2002; 3 (3): 200-214. doi: 10.1046/j.1526-4637.2002.02033.x

Velagapudi R, El-Bakoush A, Lepiarz I, Ogunrinade F, Olajide
OA. AMPK and SIRT1 activation contribute to inhibition
of neuroinflammation by thymoquinone in BV2 microglia.
Molecular and Cellular Biochemistry 2017; 435 (1-2): 149-162.
doi: 10.1007/s11010-017-3064-3

379

TÜRKÖZ et al. / Turk J Med Sci
12.

Mahmoud YK, Abdelrazek HMA. Cancer: thymoquinone
antioxidant/pro-oxidant effect as potential anticancer
remedy. Biomedicine & Pharmacotherapy = Biomédecine
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